Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry
ISSN: 0975-413X
Abstract
Identification and synthesis of impurity formed during Dabrafenib Mesylate preparation
Author(s): Madhuresh K. Sethi, Sanjay Mahajan, Bhairaiah Mara, Upendranath Veera, Anitha Nimmagadda and Purbita ChakrabortyDabrafenib Mesylate (1), a typical anti neo plastic agent drug, is used for the treatment of skin cancer. During the laboratory optimization, formation of an unknown impurity at RRT ~ 0.94 was observed in the final Dabrafenib. Origin of the impurity was possible when chloro pyrimidine intermediate (15) was converted to Dabrafenib (1).In that, the aromatic fluoro group gets converted to amine which leads to the impurity formation (Phenyl amino Dabrafenib impurity (2)). This impurity was prepared and characterized by using spectroscopic techniques. Herein the formation, synthesis and characterization of this impurity is described. Our study will be of immense help to others in obtaining chemically pure Dabrafenib Mesylate.
Select your language of interest to view the total content in your interested language
Google Scholar citation report
Citations : 25868
Der Pharma Chemica received 25868 citations as per Google Scholar report
Der Pharma Chemica peer review process verified at publons
DOWNLOADS
